DK1891011T3 - Tetrahydroquinoliner til anvendelse som modulatorer for det mitotiske motor-protein EG5 - Google Patents
Tetrahydroquinoliner til anvendelse som modulatorer for det mitotiske motor-protein EG5Info
- Publication number
- DK1891011T3 DK1891011T3 DK06754091.4T DK06754091T DK1891011T3 DK 1891011 T3 DK1891011 T3 DK 1891011T3 DK 06754091 T DK06754091 T DK 06754091T DK 1891011 T3 DK1891011 T3 DK 1891011T3
- Authority
- DK
- Denmark
- Prior art keywords
- tetrahydroquinolines
- modulators
- motor protein
- mitotic motor
- mitotic
- Prior art date
Links
- 230000000394 mitotic effect Effects 0.000 title 1
- 150000003530 tetrahydroquinolines Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102005027168A DE102005027168A1 (de) | 2005-06-13 | 2005-06-13 | Tetrahydrochinoline |
| PCT/EP2006/005297 WO2006133821A1 (de) | 2005-06-13 | 2006-06-02 | Tetrahydrochinoline zur verwendung als modulatoren des mitotischen motor- protein eg5 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1891011T3 true DK1891011T3 (da) | 2011-03-21 |
Family
ID=36870019
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06754091.4T DK1891011T3 (da) | 2005-06-13 | 2006-06-02 | Tetrahydroquinoliner til anvendelse som modulatorer for det mitotiske motor-protein EG5 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8207345B2 (da) |
| EP (1) | EP1891011B1 (da) |
| JP (1) | JP5420898B2 (da) |
| AR (1) | AR054615A1 (da) |
| AT (1) | ATE490957T1 (da) |
| AU (1) | AU2006257414B2 (da) |
| CA (1) | CA2611893C (da) |
| CY (1) | CY1111432T1 (da) |
| DE (2) | DE102005027168A1 (da) |
| DK (1) | DK1891011T3 (da) |
| ES (1) | ES2357625T3 (da) |
| PL (1) | PL1891011T3 (da) |
| PT (1) | PT1891011E (da) |
| SI (1) | SI1891011T1 (da) |
| WO (1) | WO2006133821A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE102005027170A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
| DE102006060598A1 (de) * | 2006-12-21 | 2008-06-26 | Merck Patent Gmbh | Tetrahydrobenzoisoxazole |
| DE102007013854A1 (de) * | 2007-03-20 | 2008-09-25 | Merck Patent Gmbh | Tetrahydrochinoline |
| CA2702922C (en) | 2007-10-19 | 2018-01-16 | Schering Corporation | Spiro-condensed 1,3,4-thiadiazole derivatives for inhibiting ksp kinesin activity |
| JP2013075830A (ja) * | 2010-02-03 | 2013-04-25 | Taisho Pharmaceutical Co Ltd | キノリン誘導体 |
| US9498540B2 (en) | 2013-03-15 | 2016-11-22 | Novartis Ag | Cell proliferation inhibitors and conjugates thereof |
| CN113121450A (zh) | 2014-08-29 | 2021-07-16 | Tes制药有限责任公司 | α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0395117A (ja) * | 1989-06-13 | 1991-04-19 | Kyorin Pharmaceut Co Ltd | 代謝性骨疾患治療剤 |
| EP0550635B1 (en) * | 1990-09-28 | 1995-04-19 | Pfizer Inc. | Fused ring analogs of nitrogen containing nonaromatic heterocycles |
| GB9216911D0 (en) * | 1992-08-10 | 1992-09-23 | Merck Sharp & Dohme | Therapeutic agents |
| JP2000504730A (ja) * | 1996-02-15 | 2000-04-18 | ケンブリッジ・ニューロサイエンス・インコーポレーテッド | 製薬学的活性物質及び使用方法 |
| FR2760237B1 (fr) * | 1997-02-28 | 1999-04-16 | Rhone Poulenc Rorer Sa | Thiazolobenzoheterocycles, leur preparation et les medicaments les contenant |
| WO1999067238A2 (en) * | 1998-06-25 | 1999-12-29 | Sepracor, Inc. | Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them |
| JP2000072773A (ja) * | 1998-08-28 | 2000-03-07 | Zeria Pharmaceut Co Ltd | プリン誘導体 |
| WO2002094788A1 (en) | 2001-05-22 | 2002-11-28 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| ITMI20012060A1 (it) * | 2001-10-05 | 2003-04-05 | Recordati Chem Pharm | Nuovi eterocilcli n-acilati |
| WO2004072041A1 (en) * | 2003-02-12 | 2004-08-26 | Care X S.A. | Tetrahydroquinolines as agonists of liver- x receptors |
| WO2004078758A1 (en) | 2003-03-07 | 2004-09-16 | Astrazeneca Ab | Novel fused heterocycles and uses thereof |
| CN1194969C (zh) * | 2003-05-30 | 2005-03-30 | 中国科学院大连化学物理研究所 | 对映选择性铱催化氢化取代芳香吡啶环和吡嗪环的方法 |
| DE102005027170A1 (de) * | 2005-06-13 | 2006-12-14 | Merck Patent Gmbh | Substituierte Tetrahydrochinoline |
-
2005
- 2005-06-13 DE DE102005027168A patent/DE102005027168A1/de not_active Withdrawn
-
2006
- 2006-06-02 DE DE502006008473T patent/DE502006008473D1/de active Active
- 2006-06-02 DK DK06754091.4T patent/DK1891011T3/da active
- 2006-06-02 AT AT06754091T patent/ATE490957T1/de active
- 2006-06-02 PT PT06754091T patent/PT1891011E/pt unknown
- 2006-06-02 US US11/917,309 patent/US8207345B2/en active Active
- 2006-06-02 SI SI200630942T patent/SI1891011T1/sl unknown
- 2006-06-02 EP EP06754091A patent/EP1891011B1/de not_active Not-in-force
- 2006-06-02 WO PCT/EP2006/005297 patent/WO2006133821A1/de active Application Filing
- 2006-06-02 PL PL06754091T patent/PL1891011T3/pl unknown
- 2006-06-02 ES ES06754091T patent/ES2357625T3/es active Active
- 2006-06-02 AU AU2006257414A patent/AU2006257414B2/en not_active Ceased
- 2006-06-02 JP JP2008516172A patent/JP5420898B2/ja not_active Expired - Fee Related
- 2006-06-02 CA CA2611893A patent/CA2611893C/en not_active Expired - Fee Related
- 2006-06-09 AR ARP060102410A patent/AR054615A1/es unknown
-
2011
- 2011-03-02 CY CY20111100245T patent/CY1111432T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2357625T3 (es) | 2011-04-28 |
| AU2006257414A1 (en) | 2006-12-21 |
| AU2006257414B2 (en) | 2011-08-25 |
| DE102005027168A1 (de) | 2006-12-14 |
| WO2006133821A1 (de) | 2006-12-21 |
| ATE490957T1 (de) | 2010-12-15 |
| CA2611893A1 (en) | 2006-12-21 |
| DE502006008473D1 (de) | 2011-01-20 |
| SI1891011T1 (sl) | 2011-04-29 |
| US20080200451A1 (en) | 2008-08-21 |
| JP5420898B2 (ja) | 2014-02-19 |
| CA2611893C (en) | 2013-12-17 |
| PL1891011T3 (pl) | 2011-05-31 |
| EP1891011B1 (de) | 2010-12-08 |
| AR054615A1 (es) | 2007-07-04 |
| CY1111432T1 (el) | 2015-08-05 |
| US8207345B2 (en) | 2012-06-26 |
| JP2008545805A (ja) | 2008-12-18 |
| EP1891011A1 (de) | 2008-02-27 |
| PT1891011E (pt) | 2011-03-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2084162T3 (da) | Bicykliske triazoler som proteinkinasemodulatorer | |
| DK1735286T3 (da) | Tetrahydroindazoler som cannabinoidmodulatorer | |
| DK1856042T3 (da) | Substituerede gamma-lactamer som terapeutiske midler | |
| DK1789041T3 (da) | Aryl-pyridinderivater som 11-beta-HSD1-inhibitorer | |
| DK1756096T3 (da) | Indolylderivater som lever-X-receptormodulatorer | |
| DK1797042T3 (da) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| BRPI0818205A2 (pt) | uso de um fluído aquoso alterado eletrocineticamente | |
| DK1881976T3 (da) | Substituerede amidderivater som proteinkinaseinhibitorer | |
| DK2094676T3 (da) | Ny fremgangsmåde til fremstillingen af 2-iminothiazolidin-4-on-derivater | |
| DE602005009729D1 (de) | System zur zubereitung von getränken | |
| DK1842272T3 (da) | Mellemspændingstilslutning til skibe | |
| DK2447252T3 (da) | Theramuteinmodulatorer | |
| FI20050250A0 (fi) | Opastusjärjestelmä | |
| DK1891011T3 (da) | Tetrahydroquinoliner til anvendelse som modulatorer for det mitotiske motor-protein EG5 | |
| BRPI0719514A2 (pt) | Preparações líquidas aquosas compreendendo gatifloxacina | |
| ATE533756T1 (de) | N-formyl-hydroxylamin-verbindungen | |
| DE602006019622D1 (de) | Zubereitung zur topischen anwendung enthaltend tamsulosin | |
| DE602005025919D1 (de) | Herstellungsverfahren für azopigmentdispersion | |
| DE502005007988D1 (de) | E lacksysteme | |
| DE502005007708D1 (de) | Tropfenabscheideranordnung | |
| DE102005011601A8 (de) | Abreißkupplung | |
| ITMI20051957A1 (it) | Composti e relativo uso per il controllo di fitoparogeni | |
| NO20082650L (no) | Benzenderivat eller salt derav | |
| NO20055220D0 (no) | Avskjaetingslodd for vegmast | |
| NO20051516L (no) | System for for fortoyning |